Actemra® (tocilizumab)
for Coronavirus
Actemra (tocilizumab) is an FDA-approved biologic that blocks IL-6 to reduce inflammation. It is used to treat rheumatoid arthritis, giant cell arteritis, scleroderma, juvenile idiopathic arthritis, severe cytokine release syndrome, and certain COVID-19 patients. By inhibiting IL-6, Actemra helps regulate the immune system and lessen autoimmune disease symptoms.
